Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 151–175 of 7,816 matching trials · page 7 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Tau PET/CT in Various Tau-Related Disease Patients NCT06690983 18F-S16/T807 Runs in: China · 3 sites |
NA other |
RECRUITING | 500 | Tianjin Medical University OTHER |
2026-09-08 |
|
Beta Amyloid PET/CT in Various Aβ-Related Disease NCT06725706 18F-92/AV45, 11C-PIB Runs in: China · 4 sites |
NA other |
RECRUITING | 500 | Tianjin Medical University OTHER |
2026-09-08 |
|
Effects of FEED@Home Intervention NCT06727461 Home-based Feeding EnhancEment in Dementia (Feed@home) Runs in: Hong Kong · 1 site |
NA other |
ENROLLING_BY_INVITATION | 180 | The University of Hong Kong OTHER |
2026-09-08 |
|
Alzheimer's Tau Platform: Master Protocol NCT06957418 AADvac1; Tau2 Runs in: United States · 3 sites |
PHASE2 other |
RECRUITING | 900 | Paul S. Aisen OTHER |
2026-09-08 |
|
Pan-Amyloid PET/CT in Various Amyloid-Related Disease NCT07130565 18F-92/AV45/TPZA/FT8, 11CPIB Runs in: China · 3 sites |
NA other |
RECRUITING | 500 | Tianjin Medical University OTHER |
2026-09-08 |
|
Alzheimer's Tau Platform: Regimen A - AADvac1 NCT07167966 AADvac1; Donanemab Runs in: United States · 3 sites |
PHASE2 anti-amyloid-antibody |
ENROLLING_BY_INVITATION | 450 | Paul S. Aisen OTHER |
2026-09-08 |
|
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis NCT07232459 [18F]FT8 Runs in: China · 3 sites |
NA other |
RECRUITING | 25 | Tianjin Medical University OTHER |
2026-09-08 |
|
Integrative Therapeutic Programme to Regulate Expressed Emotions Among Informal Caregivers of People With Dementia NCT07305415 Caregivers Of dementia Processing Emotions (COPE) Runs in: Hong Kong · 1 site |
NA other |
RECRUITING | 56 | The University of Hong Kong OTHER |
2026-09-08 |
|
[18F]NIDF PET Imaging in Tau-related Diseases NCT07306598 Runs in: China · 3 sites |
NA other |
RECRUITING | 20 | Tianjin Medical University OTHER |
2026-09-08 |
|
Snacks and Brain Health NCT07348406 Pecan snack; Pretzel snack Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 60 | Texas Tech University Health Sciences Center OTHER |
2026-09-08 |
|
The Existential Cognitive Intervention to Enhance Positive Aspect of Caregiving (EXCITE-PAC) in a Dementia Context NCT07396298 Existential-cognitive intervention to enhance PAC; Usual care Runs in: Hong Kong · 1 site |
NA other |
NOT_YET_RECRUITING | 304 | The University of Hong Kong OTHER |
2026-09-08 |
|
100-Year Human Aging Study NCT07563777 Comprehensive Multi-System Clinical Screening Runs in: United States · 1 site |
NA other |
RECRUITING | 1,000,000 | Longevity Metrics, Inc. INDUSTRY |
2026-09-08 |
|
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) NCT07589595 Donanemab; Placebo Runs in: Japan; South Korea; Taiwan; United States · 72 sites |
PHASE2 anti-amyloid-antibody |
RECRUITING | 350 | Eli Lilly and Company INDUSTRY |
2026-09-08 |
|
Change in Cognition and Frailty After Shunt Surgery in Idiopathic Normal Pressure Hydrocephalus (iNPH) NCT07642726 Ventriculoperitoneal shunt Runs in: Norway · 1 site |
NA other |
COMPLETED | 276 | Oslo University Hospital OTHER |
2026-09-08 |
|
Human Observatory Study NCT07646782 Multi-Domain Ecological and Clinical Data Linkage Runs in: United States · 1 site |
NA other |
RECRUITING | 1,000,000 | Longevity Metrics, Inc. INDUSTRY |
2026-09-08 |
|
Effects of Snoezelen Multisensory Therapy on Older Adults With Dementia NCT07657208 Snoezelen Multisensory Therapy; Standard Therapy Runs in: Slovenia · 1 site |
NA other |
COMPLETED | 63 | University of Primorska OTHER |
2026-09-08 |
|
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease NCT07685873 Diagnostic Test: 18F-FPyCO/SMBT-1 Runs in: China · 3 sites |
NA other |
RECRUITING | 200 | Tianjin Medical University OTHER |
2026-09-08 |
|
Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH) NCT07805967 We did not apply any interventions; only observational research was... Runs in: China · 20 sites |
NA other |
RECRUITING | 500 | Second Affiliated Hospital of Soochow University OTHER |
2026-09-08 |
|
Glutathione in Mild Cognitive Impairment NCT03493178 Glycine; N-acetylcysteine (NAC); Alanine Runs in: United States · 1 site |
EARLY_PHASE1 other |
ACTIVE_NOT_RECRUITING | 60 | Baylor College of Medicine OTHER |
2026-09-04 |
|
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease NCT04123314 Psilocybin Runs in: United States · 1 site |
EARLY_PHASE1 other |
RECRUITING | 20 | Johns Hopkins University OTHER |
2026-09-04 |
|
Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline NCT05556395 Runs in: United States · 1 site |
NA other |
RECRUITING | 150 | Johns Hopkins University OTHER |
2026-09-04 |
|
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU) NCT05658913 AV-1451 Runs in: United States · 2 sites |
NA other |
RECRUITING | 100 | University of Pennsylvania OTHER |
2026-09-04 |
|
OTC Hearing Aid and MCI NCT06112860 Over the counter hearing aid; Communication Strategies Information/... Runs in: United States · 3 sites |
NA other |
RECRUITING | 50 | Northwestern University OTHER |
2026-09-04 |
|
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) NCT06126224 KarXT; Placebo Runs in: Belgium; Canada; Chile; China; Greece; Hungary; Mexico; P... · 154 sites |
PHASE3 other |
RECRUITING | 500 | Karuna Therapeutics, Inc., a Bristol Myers Squibb company INDUSTRY |
2026-09-04 |
|
Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD) NCT06597942 TMS; Transcranial Magnetic Stimulation Sham Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 54 | University of California, Los Angeles OTHER |
2026-09-04 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial